TargaGenix

    OverviewSuggest Edit

    TargaGenix is a company that develops compounds that are effective in both drug-resistant tumors and cancer stem cells. Its compound SBT-1214 eliminates the tumor, down-regulates the stemness gene expression, and kills the cancer stem cells. The company develops a nanoemulsion formulation of chemotherapy that is a combination of a nanoparticle formulation encapsulating the novel 3rd generation taxane DHA-SBT-1214.
    TypePrivate
    Founded2013
    HQStony Brook, NY, US
    Websitetargagenix.net

    Locations

    TargaGenix is headquartered in
    Stony Brook, United States

    Location Map

    Latest Updates

    Employees (est.) (May 2020)1
    Cybersecurity ratingAMore

    Key People/Management at TargaGenix

    James E. Egan

    James E. Egan

    President and CEO

    TargaGenix Office Locations

    TargaGenix has an office in Stony Brook
    Stony Brook, NY, US (HQ)
    25 Health Sciences Drive #208
    Show all (1)

    TargaGenix Financials and Metrics

    Summary Metrics

    Founding Date

    2013

    TargaGenix Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    90/100

    SecurityScorecard logo

    TargaGenix Online and Social Media Presence

    Embed Graph

    TargaGenix Frequently Asked Questions

    • When was TargaGenix founded?

      TargaGenix was founded in 2013.

    • Who are TargaGenix key executives?

      TargaGenix's key executives are James E. Egan.

    • How many employees does TargaGenix have?

      TargaGenix has 1 employees.

    • Who are TargaGenix competitors?

      Competitors of TargaGenix include Lead Pharma, Actuate Therapeutics and Karo Pharma.

    • Where is TargaGenix headquarters?

      TargaGenix headquarters is located at 25 Health Sciences Drive #208, Stony Brook.

    • Where are TargaGenix offices?

      TargaGenix has an office in Stony Brook.

    • How many offices does TargaGenix have?

      TargaGenix has 1 office.